Lifecore Biomedical, Inc. De Ratios

Ratios May2009 May2010 May2011 May2012 May2013 May2014 May2015 May2016 May2017 May2018 May2019 May2020 May2021 May2022 May2023 May2024 May2025
Profitability
Gross Margin 15.28%14.17%16.87%16.42%14.21%13.12%12.13%14.00%16.86%14.94%14.53%24.61%38.60%35.11%27.10%32.63%31.27%
EBT Margin 6.19%3.66%3.05%6.39%7.30%4.12%3.98%-4.13%3.02%3.13%0.65%-19.15%-29.53%-18.59%-61.90%7.42%-30.01%
EBIT Margin 5.61%3.35%2.90%4.59%5.63%4.23%3.42%-4.33%3.12%2.59%0.98%-16.17%-8.75%-10.60%-21.11%-6.90%-13.38%
EBITDA Margin 3.44%1.67%1.42%4.00%5.11%4.02%2.51%-2.44%2.35%2.59%0.98%-16.17%-8.75%-10.60%-21.11%-6.90%-13.38%
Operating Margin 5.61%3.35%2.90%4.59%5.63%4.23%3.42%-4.33%3.12%2.59%0.98%-16.17%-8.75%-10.60%-21.11%-6.90%-13.38%
Net Margin 7.90%5.45%1.54%4.12%5.16%4.12%2.55%0.18%0.18%-0.23%-0.40%-12.91%-10.20%-91.61%-34.21%9.37%-34.42%
FCF Margin 6.24%0.96%2.81%5.29%2.80%1.29%1.69%-3.97%1.45%-2.63%-5.15%-27.32%-8.68%-47.21%-37.69%-14.14%-10.57%
Efficiency
Inventory Average 0.49M0.12M9.45M21.09M23.06M24.42M24.88M25.28M24.58M27.72M42.98M60.22M50.12M34.97M38.42M40.41M36.13M
Assets Average 242.00M284.32M302.28M330.04M344.56M350.63M381.66M461.90M406.30M397.69M388.29M264.12M253.75M246.65M
Equity Average 128.09M133.42M142.90M164.22M190.88M210.75M214.58M219.44M240.36M261.35M250.59M216.50M144.88M41.80M3.54M6.33M
Invested Capital 125.41M150.03M151.56M197.06M219.00M237.44M260.95M264.57M233.09M294.86M367.13M343.96M366.85M186.00M80.61M135.98M131.77M
Asset Utilization Ratio 1.311.551.581.631.381.341.371.210.390.250.290.390.510.52
Leverage & Solvency
Interest Coverage Ratio -0.00M90.709.8015.6912.3812.2410.09-10.388.036.971.05-5.57-0.99-0.76-1.27-0.60
Debt to Equity 147.220.150.350.230.170.190.260.210.250.520.770.961.12-20.068.9890.72
Debt Ratio 0.100.190.140.110.120.160.130.160.270.610.390.360.330.400.51
Equity Ratio 0.660.540.610.650.630.610.640.620.520.790.400.32-0.020.040.01
Times Interest Earned -0.00M90.709.8015.6912.3812.2410.09-10.388.036.971.05-5.57-0.99-0.76-1.27-0.60
Dividends & Payouts
FCF Payout Ratio -0.020.220.050.020.030.040.02-0.010.02-0.01
Valuation
Enterprise Value 111.39M116.94M119.24M160.26M346.36M309.08M372.63M301.91M367.57M382.85M273.82M311.01M350.35M290.00M221.64M163.21M240.55M
Market Capitalization 177.90M163.49M153.83M180.62M359.90M321.63M385.08M310.26M372.72M387.28M274.90M311.37M351.11M290.99M240.73M171.67M248.81M
Return Ratios
Return on Sales 0.09%0.05%0.02%0.04%0.05%0.04%0.03%0.00%0.00%0.00%0.00%-0.13%-0.10%-0.92%-0.34%0.02%-0.30%
Return on Capital Employed 0.08%0.11%0.08%0.07%-0.07%0.05%0.05%0.02%-0.11%-0.03%-0.06%-0.10%-0.04%-0.08%
Return on Invested Capital 0.03%0.05%0.08%0.05%-0.05%0.04%0.01%-0.05%-0.02%-0.03%-0.08%
Return on Assets 0.05%0.08%0.07%0.04%0.00%0.00%0.00%0.00%-0.05%-0.03%-0.26%-0.13%0.01%-0.16%
Return on Equity 0.10%0.03%0.09%0.14%0.10%0.07%0.00%0.00%0.00%-0.01%-0.08%-0.05%-0.70%-0.85%0.76%-6.12%